Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes

Diabetes Research and Clinical Practice

Volumn 83, Issue 3, 2009, Pages 289-294

  Momin, Scherezade ^a   Flores, Sylvia ^b   Angel B, Bárbara ^b   Codner D, Ethel ^c   Carrasco P, Elena ^d   Perez Bravo, Francisco ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

^d HOSPITAL SAN JUAN DE DIOS   (Chile)

Author keywords

CTLA 4; Genetic epidemiology; PD 1 gene; Type 1 diabetes

Indexed keywords

CELL PROTEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PROGRAMMED DEATH 1; UNCLASSIFIED DRUG;

ADOLESCENT; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE INTERACTION; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCREENING TEST;

ADOLESCENT; ANTIGENS, CD; APOPTOSIS REGULATORY PROTEINS; AUTOANTIBODIES; CHILD; DIABETES MELLITUS, TYPE 1; DNA; FEMALE; GENOTYPE; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; INSULIN ANTIBODIES; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REFERENCE VALUES;

EID: 59549104749     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.12.003     Document Type: Article

References (39)

1. Park Y. Functional evaluation of the type 1 diabetes (T1D) susceptibility candidate genes. Diabetes Res. Clin. Pract. 77S (2007) 110-115
2. Bach J.F. Infections and autoimmune diseases. J. Autoimmun. 25 (2005) 74-80
3. Alizadeh B.Z., and Koeleman B.P.C. Genetic polymorphisms in susceptibility to type 1 diabetes. Clin. Chim. Acta 387 (2008) 9-17
4. Myers M.A., Hettiarachchi K.D., Ludeman J.P., Wilson A.J., Wilson C.R., and Zimmet P.Z. Dietary microbial toxins and type 1 diabetes. Ann. N.Y. Acad. Sci. 1005 (2003) 418-422
5. Gale E.A. A missing link in the hygiene hypothesis?. Diabetologia 45 (2002) 588-594
6. Pearce S.H.S., and Merriman T.R. Genetic progress towards the molecular basis of autoimmunity. Trends Mol. Med. 12 (2006) 90-98
7. Kawasaki E., Abiru N., and Eguchi K. Prevention of type 1 diabetes: from the view point of β cell damage. Diabetes Res. Clin. Pract. 66 (2004) 27-32
8. Ounissi-Benkalha H., and Polychronakos C. The molecular genetics of type 1 diabetes: new genes and emerging mechanism. Trends Mol. Med. 14 (2008) 268-275
9. van der Merwe P.A., and Davis S.J. Molecular interactions mediating T cell antigen recognition. Annu. Rev. Immunol. 21 (2003) 659-684
10. Okazaki T., and Wang J. PD-1/PD-L pathways and autoimmunity. Autoimmunity 38 (2005) 353-357
11. Keir M.E., Butte M.J., Freeman G.J., and Sharpe A.H. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26 (2008) 677-704
12. Gregersen P.K., and Behrens T.W. Genetics of autoimmune diseases-disorders of immune homeostasis. Nat. Rev. 7 (2006) 917-928
13. Sharpe A.R., Wherry E.J., Ahmed R., and Freeman G.J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8 (2007) 239-245
14. Hiromine Y., Ikegami H., Fujisawa T., Kawabata Y., Noso S., Yamaji K., et al. Molecular scanning of the gene for programmed cell death-1 (PDCD1) as a candidate for type diabetes susceptibility. Ann. N.Y. Acad. Sci. 1079 (2006) 285-288
15. Ansari M.J., Salama A.D., Chitnis T., Smith R.N., Yagita H., Akiba H., et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198 (2003) 63-69
16. Fife B.T., Guleria I., Gubbels Bupp M., Smith R.N., Yagita H., Akiba H., et al. Insulin-induced remission in new-onset NOD mice is maintained by PD-1-PD-L1 pathway. J. Exp. Med. 203 (2006) 2737-2747
17. Sanlioglu A.D., Griffith T., Omer A., Dirice E., Sari R., Altunbas A.H., et al. Molecular mechanisms of death ligand-mediated immune modulation: a gene therapy model to prolong islet survival in type 1 diabetes. J. Cell Biochem. 104 (2008) 710-720
18. Mordes J.P., Bortell R., Blankenhorn E.P., Rossini A.A., and Greiner D.L. Rat models of type 1 diabetes: genetics, environment, and autoimmunity. ILAR J. 45 (2004) 278-291
19. Teft W., Kirchhof M., and Madrenas J. A molecular perspective of CTLA-4 function. Annu. Rev. Immunol. 24 (2006) 65-97
20. Larenas G., Arias G., Espinoza O., Charles M., Landaeta O., Villanueva S., et al. Prevalence of diabetes mellitus in a Mapuche community of Region IX, Chile. Rev. Med. Chile 113 (1985) 1121-1125
21. Carrasco E., Pérez-Bravo F., Santos J.L., López G., Calvillán M., Wolff C., et al. One of the lowest validated incidence rates of insulin dependent diabetes mellitus in the Americas: Santiago, Chile. Diabetes Res. Clin. Pract. 34 Suppl. l (1996) S153-S157
22. Carrasco E., Pérez-Bravo F., Dorman J.S., Mondragón A., and Santos J.L. Increasing incidence of type 1 diabetes in population from Santiago of Chile: trends in a period of 18 years (1986-2003). Diabetes Metab. Res. Rev. 22 1 (2006) 34-37
23. Bingley P.J., Bonifacio E., and Mueller P.W. Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes 52 (2003) 1128-1136
24. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 (2003) 506-511
25. Purohit S., Podolsky R., Collins C., Zheng W., Schatz D., Muir A., et al. Lack of correlation between the levels of soluble cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and the CT-60 genotypes. J. Autoimmune Dis. 2 (2005) 8-13
26. Sanghera D.K., Manzi S., Bontempo F., Zheng W., Schatz D., and Muir A. Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphospholipid antibodies. Hum. Genet. 115 (2004) 393-398
27. Ferreiros-Vidal I., Gómez-Reino J.J., Barros F., Carracedo A., Carreira P., González-Escribano F., et al. Association of PDCD1 with susceptibility to systemic lupus erythematosus. Arthritis Rheum. 50 (2004) 2590-2597
28. Ferreiros-Vidal I., D'Alfonso S., Papasteriades C., Skopouli F.N., Marchini M., Scorza R., et al. Bias in association studies of systemic lupus erythematosus susceptibility due to geographical variation in the frequency of a programmed cell death 1 polymorphism across Europe. Genes Immunol. 8 (2007) 138-146
29. Prokunina L., Padyukov L., Bennet A., de Faire U., Wiman B., Prince J., et al. Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis Rheum. 50 (2004) 1770-1773
30. Lin S.C., Yen J.H., Tsai J.J., Tsai W.C., Ou T.T., Liu H.W., et al. Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum. 50 (2004) 770-775
31. Prokunina L., Castillejo-López C., Oberg F., Gunnarsson I., Berg L., Magnnuson V., et al. A regulatory polymorphism in the PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet. 32 (2002) 666-669
32. Chong W.P., Ip W.K., Wong W.H., Lau C.S., Chan T.M., Lau Y.L., et al. Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immunol. 5 (2004) 484-492
33. Kong E.K., Prokunina-Olsson L., Wong W.H., Lau C.S., Chan T.M., Alarcón-Riquelme M., et al. A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum. 52 (2005) 1058-1062
34. Lee S.H., Lee Y.A., Woo D.H., Song R., Park E.K., Ryu M.H., et al. Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population. Arthritis Res. Ther. (2006) 163
35. Nielsen C., Hansen D., Husby S., Jacobsen B.B., and Lillevang S.T. Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens 62 (2003) 492-497
36. Ni R., Ihara K., Miyako K., Inuo M., Kohno H., and Hara T. PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children. Hum. Genet. 121 (2007) 223-232
37. Hiromine Y., Ikegami H., Fujisawa T., Nojima K., Kawabata Y., Noso S., et al. Trinucleotide repeats of programmed cell death-1 gene are associated with susceptibility to type 1 diabetes mellitus. Metabolism 56 (2007) 905-909
38. He F.R., Zhu H.F., Huang H., Dai Y.D., Shen X., Wang M., et al. Programmed death 1 ligands transfected dendritic cells loaded with glutamic acid decarboxylase 65 (GAD65) inhibits both alloresponse and the GAD65 reactive lymphocyte response. Clin. Exp. Immunol. 151 (2008) 86-93
39. Asad S., Nikamo P., Torn C., Landin-Olsson M., Lernmark A., Alarcón-Riquelme M., et al. No evidence of association of the PDCD1 gene with type 1 diabetes. Diabet. Med. 24 (2007) 1473-1477